Skip to main content

Philips Takes Minority Stake in BG Medicine Under R&D Alliance

NEW YORK (GenomeWeb News) – Royal Philips Electronics and BG Medicine said last week that they have formed an alliance to develop next-generation molecular healthcare products for use in areas including molecular imaging and point-of-care diagnostics.

As part of the deal, Philips has acquired an undisclosed minority stake in privately held BG.

According to the companies, the products will incorporate BG’s systems profiling technologies that identify biomarker sets associated with disease stage, progression, and treatment. Philips has also been granted access to certain of BG’s proprietary technologies and services.

Additional terms of the deal were not disclosed.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.